Clinical Trial Update: A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the within-subject variability of NN1250 in subjects with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED